Uncategorized
NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2022 and provides a business update. Financial results for 2022 include DERMAdoctor®, which NovaBay acquired on November 5, 2021. “Product sales for the fourth quarter increased 15% over the prior-year period, with continued increases in Avenova Spray unit sales through the online channel. Our Avenova companion products and our wound c